Diphenhydramine Hydrochloride

盐酸苯海拉明

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameDiphenhydramine Hydrochloride
Drug Alias Name苯海拉明diphenhydraminumdifenhidramina苯海拉明盐酸盐Benadryl +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor inverse agonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsAutistic DisorderAutism Spectrum DisorderLacerations +[14] 
Global Approved IndicationsMotion SicknessHypersensitivitySleep Initiation and Maintenance Disorders +[4] 
Approved Indications in ChinaHypersensitivity
Original Approved Country/TerritoryUnited States
Original Approved Date1946/03/04
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas Health Science Center At HoustonStanford UniversityTianjin Medical University Cancer Institute And Hospital +[9] 
Inactive CompaniesJohnson & Johnson Consumer And Personal Products WorldwideMcneil Consumer HealthcareBayer AG
Active IndicationsAutistic DisorderAutism Spectrum DisorderLacerations +[7] 
Inactive IndicationsPainMotion SicknessPain, Postoperative +[7] 

Other Information

ATC CodeD04AA32R06AA02
Related LinksWikipediaDrugBankKEGG